ไม่สามารถเล่นวิดีโอนี้
ขออภัยในความไม่สะดวก

EUDRATEC® SoluFlow: Free-flowing amorphous solid dispersions for enhanced drug solubility | Evonik

แชร์
ฝัง
  • เผยแพร่เมื่อ 8 มี.ค. 2022
  • Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology EUDRATEC® SoluFlow is just that! It works by turning a poorly soluble drug into a free-flowing amorphous solid dispersion (ASD) that can be easily compressed into tablets or filled into capsules. The unique emulsion-based process of EUDRATEC® SoluFlow can help overcome challenges with hard-to-dissolve small molecules and improve the pharmacokinetic performance of oral drug products.
    Get more information on the Evonik website: healthcare.evonik.com/en/phar...
    Don't miss the latest videos and subscribe to our TH-cam channel: / evonikindustries
    For the latest news visit us on
    LinkedIn: / evonik
    Twitter: / evonik
    Facebook: / evonik
    Instagram: / evonikofficial
    Xing: www.xing.com/companies/evonik
    Evonik. Leading Beyond Chemistry.
    Evonik is one of the world’s leading specialty chemicals companies. What drives us? Leading beyond chemistry to improve life, today and tomorrow.
    We contribute the small things that make a big difference. We make electric car batteries perform better, aircraft greener, medications more effective and 3D printers more efficient. In short: We think beyond the bounds of chemistry to make the world a better place. Today and tomorrow. We are an international group with a workforce of over 32,000 people spread across more than one hundred locations. Our daily work is shaped by global concerns, such as sustainability, diversity and digitalization. In all our business decisions, we take the present and future generations into consideration. After all, being ready for tomorrow is our business.

ความคิดเห็น • 1